• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Insulet Corp (NQ: PODD )

    268.00 +23.02 (+9.40%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Insulet Corp

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    S&P 500 Breaks 6,000 Points, Dow Soars Above 44,000, Small Caps Eye Strongest Week In 4 Years, Tesla Hits $1 Trillion: What's Driving Markets Friday?
    The S&P 500 index surged past the 6,000-point milestone, setting fresh record highs, and small-cap stocks are poised for their best weekly performance since April 2024 as investor optimism surrounding... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
    Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024. 
    Via Investor's Business Daily
    High growth, ROE and relative strength for NASDAQ:PODD, growth investors may appreciate this.
    Evaluating INSULET CORP (NASDAQ:PODD) for Growth Investment Opportunities. 
    Via Chartmill
    9 Analysts Have This To Say About Insulet
    Via Benzinga
    Why NASDAQ:PODD qualifies as a high growth stock.
    Is INSULET CORP (NASDAQ:PODD) suited for high growth investing? 
    Via Chartmill
    (PODD) - Analyzing Insulet's Short Interest
    Via Benzinga
    Here's How Much $1000 Invested In Insulet 10 Years Ago Would Be Worth Today
    Via Benzinga
    This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
    Via Benzinga
    Is NASDAQ:PODD on the Verge of a Major Breakout as a Strong Growth Stock?
    Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase. 
    Via Chartmill
    Solventum Stock Earns 81 RS Rating
    Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81. 
    Via Investor's Business Daily
    If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
    Via Benzinga
    Analyst Ratings For Insulet
    Via Benzinga
    Is NASDAQ:PODD a Fit for high Growth Investing Strategies?
    Is INSULET CORP (NASDAQ:PODD) suited for high growth investing? 
    Via Chartmill
    Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout.
    Why INSULET CORP (NASDAQ:PODD) Is a Promising High-Growth Stock in the Midst of Consolidation. 
    Via Chartmill
    Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
    Via Benzinga
    Analyst Expectations For Insulet's Future
    Via Benzinga
    Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
    Via Benzinga
    GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    Upstart, Insulet And 2 Other Stocks Executives Are Selling
    Via Benzinga
    Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
    Top-performing large-cap stocks from last week: AFRM, NTNX, MDB, BBY, GEV, TCOM, COO, PODD, VEEV, AZPN. 
    Via Benzinga
    (PODD) - Analyzing Insulet's Short Interest
    Via Benzinga
    Why Insulet Stock Was Zooming Higher This Week
    The company had encouraging news to impart about its leading insulin pump. 
    Via The Motley Fool
    Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
    Via Benzinga
    The Latest Analyst Ratings For Insulet
    Via Benzinga
    Peering Into Insulet's Recent Short Interest
    Via Benzinga
    Stocks To Watch Today: PODD, SMCI, And PAYC
    Insulet Corporation surged on FDA approval for its diabetes treatment device, while SMCI faced pressure from a short-seller report, and Paycom Software saw insider selling activity. 
    Via Talk Markets
    Exposures Product Safety
    S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
    S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
    After a blistering Thursday that saw the S&P 500 close with its best session in nearly two years — up 2.3% — Wall Street’s price action turned sluggish on a Friday lacking market-moving economic... 
    Via Benzinga
    Stocks On Track For Weekly Losses Despite Midday Gains
    The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are attempting to pare this morning's losses as they move into positive territory for the afternoon. 
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Insulin Pump Maker Insulet's Growth Catalysts Set to Boost Revenue in 2025: Analyst
    Insulet reported a Q2 adjusted EPS of $0.55, slightly missing estimates but showing strong sales growth of 23.2% year-over-year, driven by Omnipod revenue. The company raised its 2024 revenue guidance,... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.